SOAT1 and essential hypertension: To further validate the therapeutic influence of HMG-CoA reductase inhibitor on hypertension, we conducted this work and found that HMG-CoA reductase inhibitor improved elderly essential hypertension-induced vascular endothelial function impairment by blocking the JAK/STAT pathway.